SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

Been following this one for a couple of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
humpback Member Profile
 
Followed By 8
Posts 1,591
Boards Moderated 0
Alias Born 04/09/07
160x600 placeholder
Oramed to Present at Conferences Next Week "PR Newswire (US)" - 5/18/2017 8:45:00 AM
Oramed Granted Canadian Patent for GLP-1 Analog Capsule "PR Newswire (US)" - 5/9/2017 8:45:00 AM
Oramed Receives Israel Regulatory Approval to Conduct Human Study for New Oral Leptin Capsule "PR Newswire (US)" - 5/2/2017 8:45:00 AM
Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog Capsule "PR Newswire (US)" - 4/20/2017 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/19/2017 5:07:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/19/2017 5:02:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/10/2017 5:09:28 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/5/2017 4:37:20 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 4/5/2017 4:27:17 PM
Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed Scientists "PR Newswire (US)" - 4/4/2017 8:45:00 AM
Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017 "PR Newswire (US)" - 3/22/2017 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2017 12:10:46 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 3/21/2017 10:42:45 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/21/2017 9:28:42 AM
Oramed Appoints Dr. Ronald Law as Chief Strategy Officer "PR Newswire (US)" - 3/21/2017 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/2/2017 3:07:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/2/2017 3:06:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/16/2017 3:48:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/16/2017 3:46:32 PM
Statement of Beneficial Ownership (sc 13d) "Edgar (US Regulatory)" - 2/14/2017 1:26:06 PM
Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences "PR Newswire (US)" - 2/7/2017 8:30:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 2/3/2017 6:02:08 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 1/17/2017 2:41:28 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 1/11/2017 5:29:46 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 1/11/2017 5:20:01 PM
humpback   Friday, 10/31/08 03:01:57 PM
Re: axelvento post# 61
Post # of 493 
Been following this one for a couple of years now. Just bought back in. Do you think that this company has a chance to be bought out by a larger pharmaceutical company?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist